Tx for C. diff?

Tx for C. diff?

• A. Penicillin G
• B. IV vancomycin and oral metronidazole
• C. Amoxicillin
• D. Clindamycin

Answer: (B)

Treating C. difficile infection relies on delivering an active antimicrobial to the colon where the bacteria cause disease. For severe or complicated cases, the approach combines a drug that acts in the gut with another agent to provide systemic coverage when gut function is impaired. That’s why pairing a gut-active antibiotic with metronidazole is favored in these situations: vancomycin (taken so it reaches the colon) together with metronidazole (which can provide systemic effect) addresses both local colonic infection and the more severe inflammatory response that can accompany fulminant disease. In contrast, penicillin G, amoxicillin, or clindamycin are not effective treatments for C. difficile and penicillin-class antibiotics are actually common precipitants of CDI, so they’re not used to treat it. Modern practice often prioritizes oral vancomycin or fidaxomicin as first-line for CDI, with metronidazole added in severe or ileus cases, but the core idea being tested is using an agent that targets the colon alongside an additional agent for severe disease.

Treating C. difficile infection relies on delivering an active antimicrobial to the colon where the bacteria cause disease. For severe or complicated cases, the approach combines a drug that acts in the gut with another agent to provide systemic coverage when gut function is impaired. That’s why pairing a gut-active antibiotic with metronidazole is favored in these situations: vancomycin (taken so it reaches the colon) together with metronidazole (which can provide systemic effect) addresses both local colonic infection and the more severe inflammatory response that can accompany fulminant disease. In contrast, penicillin G, amoxicillin, or clindamycin are not effective treatments for C. difficile and penicillin-class antibiotics are actually common precipitants of CDI, so they’re not used to treat it. Modern practice often prioritizes oral vancomycin or fidaxomicin as first-line for CDI, with metronidazole added in severe or ileus cases, but the core idea being tested is using an agent that targets the colon alongside an additional agent for severe disease.